Visby Medical Stock

PCR-Based Medical Testing

Sign up today and learn more about Visby Medical Stock

Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.

About Visby Medical Stock

Visby Medical is a diagnostics company that develops PCR-based diagnostic tests for the detection of infectious diseases. The company develops a device platform that aims to redefine the way an illness is tested and treated. They believe that by taking a human-centric, technology-first approach to device development and they can create tools that are both highly accurate and delightful to use.

Investors

Artiman Ventures

ApplyBoard, Visby Medical

Biomedical Advanced Research and Development Authority (BARDA)

Visby Medical

J Ventures

Visby Medical

Valo Ventures

Visby Medical

Funding History

2012-12-01$6.0M
2018-01-01$9.5M
2019-04-01$100M
2021-02-01$12.3M

Management

Chief Executive Officer

Adam de la Zerda

Chief Financial Officer

Mark Ibison

Press

vcnewsdaily - Jul, 1 2022

Visby Medical Expands Series E Round

EquityZen does not have an affiliation with, formal relationship with, or endorsement from any companies featured above. This profile is based on publicly available information and is intended to be informative in nature.

Some data provided by Crunchbase

Join 630,000+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As:

Logo